Search This Site




Philadelphia Weekly - The Trouble With Spikol


 

 

 

 

Cost of the War in Iraq
(JavaScript Error)

 

 

« Suicide is never funny, but headlines about it sometimes are | Main | Friends, countrymen... »

Drug company funding studies

From Concerned, regarding this post:

EVERY study that is used to determine whether a drug gets FDA approval is a drug company funded study. Just because AZ funded the studies of Seroquel doesn't mean the the data is biased, falsified, or misrepresented.

Check out Philip Dawdy's post on this subject to see another point of view.

Comments

Actually, concerned, it's the DEFINITION of biased. AZ has a vested interest in securing a "positive outcome" for these studies. They want to sell their product, just as any private institution does. Independent, objective research it is not.

HI liz,
Just wanted to thank you for keeping up your blog.
love hearing how you are doing...
How are you doing?
bizi

With the advent of managed medicine, cost-effective care, outcome based medicine and other euphemisms for bad medicine independent research has died a rapid death. Even in academic settings almost all research is drug company sponsored with a clear underlying bias to prove the efficacy of medications pending release or pending a new indication. Positive outcomes equals potential sales, equals money for the drug company, equals future study funding for the researcher.

Medicine has become largely consumer driven- witness the $$$$ being made by laser centers, plastic surgeons and erectile dysfunction cures.(Do you have any idea how hard it is to not joke after a sentence which contains the word
"erectile"?
I will be strong.)

The heck with my last comment.Very,very cool mentions in the NYT today!!! Congratulations. Who is the cute chick on the bed?

It's great to find this blog.

Post a comment

(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)

About

self portrait web final.JPG

Liz Spikol is senior contributing editor of Philadelphia Weekly. She writes the award-winning column The Trouble With Spikol, which began as a chronicle of her struggle with mental illness, and has since expanded into humorous musings on everything from graphic novels to how to use a mop. She also writes the paper's book review column, Lit Gloss. This blog -- named one of the Top 10 Bipolar Blogs of 2007 by PsychCentral -- is about mental illness policy, news, personal journeys and more.